Category: Analysis
Deeper reads connecting technology headlines to strategy, competition, policy, infrastructure and market pricing.
-
Google’s 40x Quantum Error Cut Explained
Google cut quantum error rates in magic states by 40 times. Here’s why this matters for the path to useful quantum computers and what comes next.
-
Rogue AI Agents Broke Into Live Systems. Now What?
India says rogue AI agents breached live corporate systems, exposing a new class of autonomous cyber risk that security teams are not built to handle.
-
JPEG XL vs. AVIF: Which Image Format Wins the Web?
JPEG XL and AVIF both promise smaller files and better quality, but browsers disagree. Here’s how the two formats compare for real web use cases.
-
Utah’s AI Sandbox Tests Health Care’s Regulatory Limits
Utah’s AI sandbox expands into health care with new pilots, testing how regulators can oversee medical AI without stifling innovation.
-
The Quiet Trade in Dead Books That Trains AI
Libraries and publishers are wrestling with a little-seen trade: books scanned and sometimes destroyed to feed AI training datasets.
-
AI IPO Down 52%: Why Wall Street Still Sees a Double
One hot AI IPO has shed half its value while analysts still project a double. We unpack the quantum computing bet behind the hype and the risk.
-
The AI Wealth Boom Will Be Bumpy, and That’s the Point
Fed’s Warsh says AI’s path to wealth will be “very bumpy” but ultimately “very good.” Here’s what that volatility actually means for tech and markets.
-
A Virginia High School Is Getting a Quantum Computer. Why That Matters
A Virginia high school is getting a quantum computer, a sign that quantum education is moving from graduate labs into classrooms far earlier than expected.
-
CERN Taps Mistral for Flare: A Physics-Specific AI Model
CERN and Mistral are building Flare, a physics-tuned AI model. Here’s why specialized scientific AI could matter more than another general chatbot.
-
AI in Oncology Is Moving Faster Than Its Rulebook
AI in oncology is reshaping trials and workflows, but regulators and clinicians are still figuring out how to prove these models actually help patients.